The FDA approved Zulresso, the first treatment specifically intended for women with postpartum depression.
Pharmacy
In the latest blow to the philanthropic image cultivated by the founding family of Purdue Pharma, the National Portrait Gallery in London will not move forward with a $1.3 million pledge from a charitable organization overseen by some members of…
CVS Health donated $1.4 million to 82 colleges and universities to help advocate for, adopt and implement tobacco-free policies on their campuses.
Mylan and Hospira issued recalls for injectable medications after potentially dangerous particulate matter was discovered in the vials.
A class action lawsuit was filed against AbbVie for allegedly using patent thickets and colluding with biosimilar drugmakers to maintain monopoly for its blockbuster rheumatoid arthritis drug Humira, according to The Center for Biosimilars.
In recent years, it has become the norm to see shortages of drugs for cancer and other diseases — and the problem is only getting worse, Yoram Unguru, MD, a pediatric hematologist and oncologist at The Herman & Walter Samuelson…
In an effort to reduce prescription drug costs in the last year, nearly one in every five patients asked their physician for a lower-cost medication, according to a new report from the CDC.
Eli Lilly received a tax abatement worth $7 million over the next 10 years with the Indianapolis City-County Council's approval, according to The Indianapolis Business Journal.
Sanofi is working to find a new CEO to succeed Olivier Brandicourt, who will reach the drugmaker's mandatory retirement age in less than two years, according to Reuters.
Gilead Sciences increased the U.S. prices of its top six antiviral drugs that treat HIV by 4.9 percent, according to financial and investment news site Barron's.